Cambridge Investment Research Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,615
| Closed | -$246K | – | 3274 |
|
|
2022
Q3 | $246K | Buy |
+3,615
| New | +$246K | ﹤0.01% | 2534 |
|
|
2022
Q2 | – | Sell |
-7,387
| Closed | -$256K | – | 3269 |
|
|
2022
Q1 | $256K | Sell |
7,387
-900
| -11% | -$31.2K | ﹤0.01% | 2677 |
|
|
2021
Q4 | $243K | Buy |
+8,287
| New | +$243K | ﹤0.01% | 2719 |
|
|
2020
Q4 | – | Sell |
-6,159
| Closed | -$340K | – | 2806 |
|
|
2020
Q3 | $340K | Buy |
6,159
+370
| +6% | +$20.4K | ﹤0.01% | 1855 |
|
|
2020
Q2 | $365K | Sell |
5,789
-651
| -10% | -$41K | ﹤0.01% | 1738 |
|
|
2020
Q1 | $329K | Buy |
6,440
+768
| +14% | +$39.2K | ﹤0.01% | 1617 |
|
|
2019
Q4 | $451K | Buy |
5,672
+717
| +14% | +$57K | ﹤0.01% | 1648 |
|
|
2019
Q3 | $240K | Buy |
4,955
+200
| +4% | +$9.69K | ﹤0.01% | 1990 |
|
|
2019
Q2 | $250K | Sell |
4,755
-1,370
| -22% | -$72K | ﹤0.01% | 1869 |
|
|
2019
Q1 | $324K | Sell |
6,125
-205
| -3% | -$10.8K | ﹤0.01% | 1759 |
|
|
2018
Q4 | $260K | Sell |
6,330
-525
| -8% | -$21.6K | ﹤0.01% | 1754 |
|
|
2018
Q3 | $260K | Buy |
6,855
+1,555
| +29% | +$59K | ﹤0.01% | 1887 |
|
|
2018
Q2 | $240K | Buy |
+5,300
| New | +$240K | ﹤0.01% | 1881 |
|